Kyle Mikson CFA
Stock Analyst at Canaccord Genuity
(4.79)
# 567
Out of 5,118 analysts
488
Total ratings
47.8%
Success rate
17.6%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDSX Biodesix | Reiterated: Buy | $35 | $8.53 | +310.32% | 30 | Nov 6, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $40 | $32.52 | +23.00% | 28 | Nov 6, 2026 | |
| GH Guardant Health | Reiterated: Buy | $205 | $150.87 | +35.88% | 42 | Nov 6, 2026 | |
| NTRA Natera | Reiterated: Buy | $500 | $310.67 | +60.94% | 39 | Nov 6, 2026 | |
| QSI Quantum-Si incorporated | Reiterated: Hold | $1 | $1.33 | -24.81% | 23 | Nov 6, 2026 | |
| TXG 10x Genomics | Reiterated: Buy | $100 | $59.28 | +68.69% | 33 | Nov 6, 2026 | |
| BLLN BillionToOne | Reiterated: Buy | $120 | $113.94 | +5.32% | 2 | Nov 5, 2026 | |
| CAI Caris Life Sciences | Reiterated: Hold | $30 | $25.23 | +18.91% | 11 | Nov 5, 2026 | |
| GRAL GRAIL | Reiterated: Buy | $150 | $121.44 | +23.52% | 19 | Nov 5, 2026 | |
| PACB Pacific Biosciences of California | Reiterated: Buy | $3 | $2.26 | +33.04% | 37 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $24.16 | +106.95% | 13 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $76.05 | +24.92% | 14 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $99 | $78.56 | +26.02% | 3 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $300 | $213.13 | +40.76% | 53 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $180 | $173.49 | +3.75% | 14 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.398 | +653.77% | 20 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $11 | $5.81 | +89.33% | 27 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $205 | $120.79 | +69.72% | 4 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $2.90 | +3.63% | 32 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.63 | +145.40% | 4 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $90 | $62.37 | +44.30% | 11 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 200p → 180p | 206p | -12.54% | 10 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $267 | $21.92 | +1,118.70% | 1 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $5 | $0.0002 | n/a | 12 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $15 | $11.15 | n/a | 3 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.57 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.1959 | n/a | 1 | Mar 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.18 | n/a | 1 | Jan 28, 2021 |
Biodesix
Nov 6, 2026
Reiterated: Buy
Price Target: $35
Current: $8.53
Upside: +310.32%
Castle Biosciences
Nov 6, 2026
Reiterated: Buy
Price Target: $40
Current: $32.52
Upside: +23.00%
Guardant Health
Nov 6, 2026
Reiterated: Buy
Price Target: $205
Current: $150.87
Upside: +35.88%
Natera
Nov 6, 2026
Reiterated: Buy
Price Target: $500
Current: $310.67
Upside: +60.94%
Quantum-Si incorporated
Nov 6, 2026
Reiterated: Hold
Price Target: $1
Current: $1.33
Upside: -24.81%
10x Genomics
Nov 6, 2026
Reiterated: Buy
Price Target: $100
Current: $59.28
Upside: +68.69%
BillionToOne
Nov 5, 2026
Reiterated: Buy
Price Target: $120
Current: $113.94
Upside: +5.32%
Caris Life Sciences
Nov 5, 2026
Reiterated: Hold
Price Target: $30
Current: $25.23
Upside: +18.91%
GRAIL
Nov 5, 2026
Reiterated: Buy
Price Target: $150
Current: $121.44
Upside: +23.52%
Pacific Biosciences of California
Nov 5, 2026
Reiterated: Buy
Price Target: $3
Current: $2.26
Upside: +33.04%
Nov 5, 2026
Reiterated: Hold
Price Target: $50
Current: $24.16
Upside: +106.95%
Nov 3, 2026
Reiterated: Buy
Price Target: $95
Current: $76.05
Upside: +24.92%
Oct 30, 2026
Reiterated: Buy
Price Target: $80 → $99
Current: $78.56
Upside: +26.02%
Oct 30, 2026
Reiterated: Hold
Price Target: $300
Current: $213.13
Upside: +40.76%
Oct 28, 2026
Reiterated: Hold
Price Target: $180
Current: $173.49
Upside: +3.75%
Oct 23, 2026
Reiterated: Buy
Price Target: $3
Current: $0.398
Upside: +653.77%
Oct 19, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $5.81
Upside: +89.33%
Oct 12, 2026
Reiterated: Buy
Price Target: $120 → $205
Current: $120.79
Upside: +69.72%
Aug 17, 2026
Reiterated: Hold
Price Target: $4 → $3
Current: $2.90
Upside: +3.63%
Aug 11, 2026
Reiterated: Buy
Price Target: $4
Current: $1.63
Upside: +145.40%
Aug 4, 2026
Reiterated: Buy
Price Target: $75 → $90
Current: $62.37
Upside: +44.30%
Jul 14, 2026
Reiterated: Buy
Price Target: 200p → 180p
Current: 206p
Upside: -12.54%
Jun 18, 2026
Reiterated: Buy
Price Target: $267
Current: $21.92
Upside: +1,118.70%
Jul 29, 2024
Reiterated: Hold
Price Target: $3 → $5
Current: $0.0002
Upside: n/a
Jun 1, 2021
Reiterated: Buy
Price Target: $13 → $15
Current: $11.15
Upside: n/a
Mar 29, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $1.57
Upside: n/a
Mar 9, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $0.1959
Upside: n/a
Jan 28, 2021
Initiated Coverage: Buy
Price Target: $10
Current: $0.18
Upside: n/a